SCOPUS 정보 검색 플랫폼

European Heart Journal

Volumn 22, Issue 11, 2001, Pages 919-925

At what coronary risk level is it cost-effective to initiate cholesterol lowering drug treatment in primary prevention?

(1) Johannesson, Magnus a

a STOCKHOLM SCHOOL OF ECONOMICS (Sweden)

Author keywords

Cholesterol; Coronary heart disease; Cost effectiveness; Primary prevention

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; RISK FACTOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTILIPEMIC AGENTS; CORONARY DISEASE; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SWEDEN;

EID: 0034935873 PISSN: 0195668X EISSN: None Source Type: Journal
DOI: 10.1053/euhj.2000.2484 Document Type: Article

Times cited : (52)

References (34)

1
- 0003647846
- Stockholm: Statistics Sweden
- (1998) Statistical Yearbook of Sweden 1999

2
- 0026011159
- Cardiovascular disease risk profiles
- (1990) Am Heart J , vol.121 , pp. 293-298
- Anderson, K.M.¹ Odell, P.M.² Wilson, P.W.F.³ Kannel, W.B.⁴

3
- 0025216049
- The cholesterol facts: A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease: A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute
- (1990) Circulation , vol.81 , pp. 1721-1733
- LaRosa, J.C.¹ Hunninghake, D.² Bush, D.³

4
- 0027987849
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
- (1994) Lancet , vol.344 , pp. 1383-1389

5
- 0028883828
- Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
- (1995) N Engl J Med , vol.333 , pp. 1301-1307
- Shepherd, J.¹ Cobbe, S.M.² Ford, I.³

6
- 0342981862
- The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
- (1996) N Engl J Med , vol.335 , pp. 1001-1009
- Sacks, F.M.¹ Pfeffer, M.A.² Moye, L.A.³

7
- 0032487931
- Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
- (1998) N Engl J Med , vol.339 , pp. 1349-1357

8
- 0032572086
- Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS
- (1998) JAMA , vol.279 , pp. 1615-1622
- Downs, J.R.¹ Clearfield, M.² Weis, S.³

9
- 0029782690
- The role of cost-effectiveness analysis in health and medicine
- (1996) JAMA , vol.276 , pp. 1172-1177
- Russel, L.B.¹ Gold, M.R.² Siegel, J.R.³ Daniels, N.⁴ Weinstein, M.C.⁵

10
- 1842404801
- Cost-effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease
- (1997) N Engl J Med , vol.336 , pp. 332-336
- Johannesson, M.¹ Jönsson, B.² Kjekshus, J.³ Olsson, A.G.⁴ Pedersen, T.R.⁵ Wedel, H.⁶

11
- 0026090020
- Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease
- (1991) JAMA , vol.265 , pp. 1145-1151
- Goldman, L.¹ Weinstein, M.C.² Goldman, P.A.³ Williams, L.W.⁴

12
- 0027243348
- Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
- (1993) JAMA , vol.269 , pp. 3015-3023

13
- 0030578660
- Targeting lipid-lowering drug therapy for primary prevention of coronary heart disease: An updated Sheffield table
- (1996) Lancet , vol.348 , pp. 387-388
- Ramsay, L.E.¹ Haq, I.U.² Jackson, P.R.³ Yeo, W.W.⁴ Pickin, D.M.⁵ Payne, J.N.⁶

14
- 0030566347
- The Sheffield table for primary prevention of coronary heart disease: Corrected
- (1996) Lancet , vol.348 , pp. 1251-1252
- Ramsay, L.E.¹ Haq, I.U.² Jackson, P.R.³ Yeo, W.W.⁴

15
- 0031728287
- Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
- (1998) Atherosclerosis , vol.140 , pp. 199-270
- Wood, D.¹ DeBacker, G.² Faergeman, O.³ Graham, J.⁴ Mancia, G.⁵ Pyörälä, K.⁶

16
- 0029794708
- Recommendations of the Panel on Cost-Effectiveness in Health and Medicine
- (1996) JAMA , vol.276 , pp. 1253-1258
- Weinstein, M.C.¹ Siegel, J.E.² Gold, M.R.³ Kamlet, K.S.⁴ Russel, L.B.⁵

17
- 0030915977
- Accounting for future costs in medical cost-effectiveness analysis
- (1997) J Health Econ , vol.16 , pp. 33-64
- Meltzer, D.¹

18
- 0031989253
- Some reflections on cost-effectiveness analysis
- (1998) Health Econ , vol.7 , pp. 1-7
- Johannesson, M.¹ Meltzer, D.²

19
- 0025153446
- Cost-effectiveness of screening perimenopausal white women for osteoporosis: Bone densitometry and hormone replacement therapy
- (1990) Ann Intern Med , vol.113 , pp. 594-603
- Tosteson, A.N.¹ Rosenthal, D.I.² Melton III, L.J.³ Weinstein, M.C.⁴

20
- 0025136710
- Screening for hypertension
- (1990) Ann Intern Med , vol.112 , pp. 192-202
- Littenberg, G.¹ Garber, A.M.² Sox H.C., Jr.³

21
- 0025758671
- An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction
- (1991) Am J Cardiol , vol.67 , pp. 789-796
- Hay, J.W.¹ Wittels, E.H.² Gotto A.M., Jr.³

22
- 0031671423
- US and UK health economics: Two disciplines separated by a common language?
- (1998) Health Econ , vol.7
- Newhouse, J.P.¹

23
- 0348098811
- The valur of health: 1970-1990
- (1998) American Economic Review Papers and Proceedings , vol.88 , pp. 97-100
- Cutler, D.¹ Richardson, E.²

24
- 84907110059
- A computer simulation model for cost-effectiveness analysis of cardiovascular disease prevention
- (1991) Med Inf , vol.16 , pp. 355-362
- Johannesson, M.¹ Hedbrant, J.² Jönsson, B.³

25
- 0030186979
- The cost-effectiveness of lipid lowering in Swedish primary health care
- (1996) J Intern Med , vol.240 , pp. 23-29
- Johannesson, M.¹ Borgquist, L.² Jönsson, B.³ Lindholm, L.H.⁴

26
- 0004608426
- Stockholm: The National Board of Health and Welfare
- (1997) Causes of Death 1995. Statistics-Health and Diseases 1997: 3

27
- 0030619301
- Income-related inequalities in health: Some international comparisons
- (1997) J Health Econ , vol.16 , pp. 93-112
- Van Doorslaer, E.¹ Wagstaff, A.² Bleichrodt, H.³

28
- 0004550560
- Stockholm: Läkemedelsinformation AB
- FASS 1998, Pharmaceutical Specialities in Sweden , pp. 1998

29
- 0032798432
- Costs of coronary heart disease and stroke: The case of Sweden
- (1999) J Intern Med , vol.246 , pp. 151-159
- Zethraeus, N.¹ Molin, T.² Henriksson, P.³ Jönsson, B.⁴

30
- 0030765401
- Incorporating future costs in medical cost-effectiveness analysis: Implications for the cost-effectiveness of the treatment of hypertension
- (1997) Med Decis Making , vol.17 , pp. 382-389
- Johannesson, M.¹ Meltzer, D.² O'Conor, R.M.³

31
- 0032859354
- Health-state utilities in a general population in relation to age, gender, and socioeconomic factors
- (1999) Eur J Public Health , vol.9 , pp. 211-217
- Lundberg, L.¹ Johannesson, M.² Isacson, D.G.L.³ Borgquist, L.⁴

32
- 0027497944
- Stability of timetradeoff utilities in survivors of myocardial infarction
- (1993) Med Decis Making , vol.13 , pp. 161-165
- Tsevat, J.¹ Goldman, L.² Soukup, J.R.³

33
- 0027947524
- Quality of life six months after myocardial infarction treated with thrombolytic therapy
- (1994) Med J Aust , vol.161 , pp. 532-536
- Glasziou, P.P.¹ Bromwich, S.² Simes, R.J.³

34
- 0032510662
- Primary prevention of coronary heart disease: Guidance from Framingham. A statement for health care professionals from the AHA Task Force on Risk Reduction
- (1998) Circulation , vol.97 , pp. 1876-1887
- Grundy, S.M.¹ Ballady, G.J.² Criqui, M.H.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.